Australian Clinical Labs Limited

ASX:ACL ISIN:AU0000148496

Australian Clinical Labs Limited (ASX:ACL) is a leading Australian private provider of pathology services. ACL is one of the largest private hospital pathology businesses nationally and in its established regions of Western Australia, Victoria, New South Wales, Queensland, South Australia and the Northern Territory, has an equivalent market position in community pathology to Sonic Healthcare and Healius. ACL also has a growing presence in the Australian Capital Territory.

 
 
    

View in Other Languages

News

Alchemia Limited (ASX:ACL) Announces Half-year Results for Period Ended 31 December 2013

🕔2/18/2014 5:31:58 PM 5558

Alchemia Limited (ASX:ACL) a drug discovery and development company, is pleased to announce its half year results for the six months ended 31 December 2013.

Read Full Article

Asian Activities Report for September 28, 2011: Fletcher Building (ASX:FBU) Announce Major Supply Contract for the Queensland Coal Seam Gas Market

🕔9/28/2011 12:02:16 PM 11471

Asian Activities Report for September 28, 2011 includes: Fletcher Building Limited (ASX:FBU) said today that Iplex Pipelines has been awarded a A$120 million contract for the supply of polyethylene pipe; Integra Mining Limited (ASX:IGR) reported aircore drilling results from reconnaissance drilling in the Mt Monger area; African Iron Limited (ASX:AKI) provides an update on drilling activities at its 92%-owned Mayoko iron ore project in the Republic of Congo; Alchemia Limited (ASX:ACL) said today that its leading cancer product HA-Irinotecan has received very promising trial results; Tata Communications (BOM:500483) has become one of the few global carriers to extend its Global IP/VPN service offerings into Pakistan.

Read Full Article

Benitec Limited (ASX:BLT) Announce A Board and Senior Management Update

🕔3/29/2010 10:54:56 AM 11624

Benitec Limited (ASX:BLT) (PINK:BNIKF) announced today that Ms Sue MacLeman will step down from the role of Chief Executive Officer (CEO) and Managing Director to pursue other opportunities. She has agreed however to stay actively involved with Benitec as a Strategic Advisor at this exciting time for the Company. A transition arrangement has been put in place. Mr Mel Bridges and Dr John Chiplin will both move to Executive Director roles within the Company and the Board will be further strengthened in the coming months.

Read Full Article
###

42,520 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 26) (Last 30 Days: 123) (Since Published: 11205) 

Company Data

    Headquarters
  • 1868-1892 Dandenong Road
    Clayton VIC 3168
    Australia
  • Telephone
  • (03) 9538 6777 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.clinicallabs.com.au

More News Results

  • 2024/11/01: Change in substantial shareholding from AEF*
  • 2024/10/31: Update - Notification of buy-back - ACL*
  • 2024/10/30: Becoming a substantial holder*
  • 2024/10/29: Becoming a substantial holder from MUFG*
  • 2024/10/29: Becoming a substantial holder from CBA*
  • 2024/10/29: Becoming a substantial holder*
  • 2024/10/29: Final Director's Interest Notice*
  • 2024/10/29: Final Director's Interest Notice*
  • 2024/10/29: Update - Notification of buy-back - ACL*
  • 2024/10/28: Becoming a substantial holder*
*refer to company website